- Title
-
Probiotic treatment reduces appetite and glucose level in the zebrafish model
- Authors
- Falcinelli, S., Rodiles, A., Unniappan, S., Picchietti, S., Gioacchini, G., Merrifield, D.L., Carnevali, O.
- Source
- Full text @ Sci. Rep.
ZFIN is incorporating published figure images and captions as part of an ongoing project. Figures from some publications have not yet been curated, or are not available for display because of copyright restrictions. |
|
ZFIN is incorporating published figure images and captions as part of an ongoing project. Figures from some publications have not yet been curated, or are not available for display because of copyright restrictions. |
Transmission Electron Microscopy (TEM) shows the ultrastructure of the intestinal in control and probiotic treated zebrafish. PHENOTYPE:
|
BODIPY C5 staining shows an accumulation of short chain fatty acids (SCFA) in the intestine and gallbladder of probiotic treated larvae. Representative fluorescent images of live 8 dpf zebrafish immersed in BODIPY C5 for 1 hour. Images revealed a remarkable presence of SCFA in probiotic treated larvae (B–D) that exhibited higher fluorescent signal in the intestine and gallbladder compared to the control one (A–C). Red asterisk: gallbladder; I: intestine. Scale bar: 500 μm. Probiotic treated larvae display significantly enhancement of fluorescent signal in the gallbladder (E) and in the intestine (F) with respect to the control group, highlighting an accumulation of short chain fatty acids (SCFA). Quantification of fluorescence is expressed in a.u. The data are reported as mean ± s.d from 3 individual experiments. The significance of differences between groups for these values was determined using Student’s t-test. Data are the mean ± s.d. Asterisks indicates significant differences (P < 0.05). PHENOTYPE:
|